Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.8NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.507NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.507NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.507NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.54NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.54NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.54NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.196NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.196NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.196NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.57NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.57NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.57NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.34NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.34NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.34NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.459NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.459NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.459NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.117NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.117NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.117NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.381NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.381NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.381NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.237NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.237NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.237NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.382NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.382NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.382NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.395NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.395NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.395NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.37NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.37NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.37NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.61NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.61NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.61NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.40NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.40NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.40NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.153NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.153NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used